Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

[Possibilities of immune checkpoint inhibitor therapy for patients with metastatic non-small cell lung cancer].

Téglási V, Moldvay J, Szállási Z, Reiniger L.

Magy Onkol. 2019 Sep 18;63(3):233-238. Epub 2019 Jul 26. Hungarian.

2.

Influence of mutagenic versus non-mutagenic pre-operative chemotherapy on the immune infiltration of residual breast cancer.

Tőkés AM, Rusz O, Cserni G, Tóth E, Rubovszky G, Tőkés T, Vízkeleti L, Reiniger L, Kószó R, Kahán Z, Kulka J, Donia M, Vörös A, Szallasi Z.

Acta Oncol. 2019 Jul 4:1-9. doi: 10.1080/0284186X.2019.1633015. [Epub ahead of print]

PMID:
31271119
3.

Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib.

Gángó A, Alpár D, Galik B, Marosvári D, Kiss R, Fésüs V, Aczél D, Eyüpoglu E, Nagy N, Nagy Á, Krizsán S, Reiniger L, Farkas P, Kozma A, Ádám E, Tasnády S, Réti M, Matolcsy A, Gyenesei A, Mátrai Z, Bödör C.

Int J Cancer. 2019 Jun 10. doi: 10.1002/ijc.32502. [Epub ahead of print]

PMID:
31180577
4.

PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.

Téglási V, Pipek O, Lózsa R, Berta K, Szüts D, Harkó T, Vadász P, Rojkó L, Döme B, Bagó AG, Tímár J, Moldvay J, Szállási Z, Reiniger L.

Clin Lung Cancer. 2019 Sep;20(5):363-369.e2. doi: 10.1016/j.cllc.2019.05.008. Epub 2019 May 15.

PMID:
31178388
5.

Comprehensive analysis of circulating microRNAs in plasma of patients with pituitary adenomas.

Németh K, Darvasi O, Likó I, Szücs N, Czirják S, Reiniger L, Szabó B, Krokker L, Pállinger É, Igaz P, Patócs A, Butz H.

J Clin Endocrinol Metab. 2019 May 21. pii: jc.2018-02479. doi: 10.1210/jc.2018-02479. [Epub ahead of print]

PMID:
31112271
6.

Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma.

Reiniger L, Téglási V, Pipek O, Rojkó L, Glasz T, Vágvölgyi A, Kovalszky I, Gyulai M, Lohinai Z, Rásó E, Tímár J, Döme B, Szállási Z, Moldvay J.

Acta Oncol. 2019 Aug;58(8):1087-1094. doi: 10.1080/0284186X.2019.1598575. Epub 2019 Apr 19.

PMID:
31002007
7.

Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.

Krokker L, Nyírő G, Reiniger L, Darvasi O, Szücs N, Czirják S, Tóth M, Igaz P, Patócs A, Butz H.

Neurochem Res. 2019 Apr 3. doi: 10.1007/s11064-019-02789-2. [Epub ahead of print]

PMID:
30945144
8.

Corrigendum to: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Kulka J, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2019 Mar 30. pii: mdz081. doi: 10.1093/annonc/mdz081. [Epub ahead of print] No abstract available.

9.

Origin and Distribution of Connective Tissue and Pericytes Impacting Vascularization in Brain Metastases With Different Growth Patterns.

Téglási V, Csűry DT, Dezső K, Bugyik E, Szabó V, Szállási Z, Paku S, Reiniger L.

J Neuropathol Exp Neurol. 2019 Apr 1;78(4):326-339. doi: 10.1093/jnen/nlz007.

PMID:
30816955
10.

The genomic imprint of cancer therapies helps timing the formation of metastases.

Németh E, Krzystanek M, Reiniger L, Ribli D, Pipek O, Sztupinszki Z, Glasz T, Csabai I, Moldvay J, Szallasi Z, Szüts D.

Int J Cancer. 2019 Aug 1;145(3):694-704. doi: 10.1002/ijc.32159. Epub 2019 Feb 18.

PMID:
30694556
11.

Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas.

Németh K, Darvasi O, Likó I, Szücs N, Czirják S, Reiniger L, Szabó B, Kurucz PA, Krokker L, Igaz P, Patócs A, Butz H.

J Endocrinol Invest. 2019 Aug;42(8):931-940. doi: 10.1007/s40618-019-1005-6. Epub 2019 Jan 25.

12.

Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.

Mózes R, Gángó A, Sulák A, Vida L, Reiniger L, Timár B, Krenács T, Alizadeh H, Masszi T, Gaál-Weisinger J, Demeter J, Csomor J, Matolcsy A, Kajtár B, Bödör C.

Pathology. 2019 Apr;51(3):301-307. doi: 10.1016/j.pathol.2018.11.007. Epub 2018 Dec 31.

PMID:
30606612
13.

[Aspects of nutrition therapy of an infant with central nervous system tumour].

Györke E, Vargáné Németh A, Balogh M, Masát P, Benyó G, Reiniger L, Nagy G, Hauser P.

Magy Onkol. 2018 Dec 12;62(4):237-241. Epub 2018 Nov 22. Hungarian.

14.

Case of the month 1-2019: CNS high-grade neuroepithelial tumor with BCOR alteration.

Haberler C, Reiniger L, Rajnai H, Kalev O, Gelpi E, Tamesberger M, Pietsch T.

Clin Neuropathol. 2019 Jan/Feb;38(1):4-7. doi: 10.5414/NP301162. No abstract available.

15.

EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.

Szurián K, Csala I, Marosvári D, Rajnai H, Dezső K, Bödör C, Piurkó V, Matolcsy A, Reiniger L.

Exp Mol Pathol. 2018 Oct;105(2):161-165. doi: 10.1016/j.yexmp.2018.07.009. Epub 2018 Jul 18.

PMID:
30031020
16.

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas.

Németh K, Szücs N, Czirják S, Reiniger L, Szabó B, Barna G, Karászi K, Igaz P, Zivkovic V, Korbonits M, Patócs A, Butz H.

Oncotarget. 2018 Jun 26;9(49):29180-29192. doi: 10.18632/oncotarget.25650. eCollection 2018 Jun 26.

17.

Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer.

Sztupinszki Z, Diossy M, Krzystanek M, Reiniger L, Csabai I, Favero F, Birkbak NJ, Eklund AC, Syed A, Szallasi Z.

NPJ Breast Cancer. 2018 Jul 2;4:16. doi: 10.1038/s41523-018-0066-6. eCollection 2018.

18.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2018 Sep 1;29(9):1948-1954. doi: 10.1093/annonc/mdy216. Erratum in: Ann Oncol. 2019 Mar 30;:.

19.

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients.

Rojkó L, Reiniger L, Téglási V, Fábián K, Pipek O, Vágvölgyi A, Agócs L, Fillinger J, Kajdácsi Z, Tímár J, Döme B, Szállási Z, Moldvay J.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1219-1226. doi: 10.1007/s00432-018-2642-4. Epub 2018 Apr 19.

PMID:
29675791
20.

Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated Phosphorylation.

Marosvári D, Nagy N, Kriston C, Deák B, Hajdu M, Bödör C, Csala I, Bagó AG, Szállási Z, Sebestyén A, Reiniger L.

J Neuropathol Exp Neurol. 2018 Apr 1;77(4):268-273. doi: 10.1093/jnen/nlx121.

PMID:
29361117
21.

Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.

Szurián K, Csala I, Piurkó V, Deák L, Matolcsy A, Reiniger L.

Leuk Res. 2017 Jul;58:39-42. doi: 10.1016/j.leukres.2017.04.002. Epub 2017 Apr 4.

PMID:
28407516
22.

Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.

Téglási V, Reiniger L, Fábián K, Pipek O, Csala I, Bagó AG, Várallyai P, Vízkeleti L, Rojkó L, Tímár J, Döme B, Szállási Z, Swanton C, Moldvay J.

Neuro Oncol. 2017 Aug 1;19(8):1058-1067. doi: 10.1093/neuonc/now309.

23.

Morphological and molecular characterization of Cladosporium cladosporioides species complex causing pecan tree leaf spot.

Walker C, Muniz MF, Rolim JM, Martins RR, Rosenthal VC, Maciel CG, Mezzomo R, Reiniger LR.

Genet Mol Res. 2016 Sep 16;15(3). doi: 10.4238/gmr.15038714.

PMID:
27706736
24.

Simulating the selfing and migration of Luehea divaricata populations in the Pampa biome to investigate the conservation potential of their genetic resources.

Serrote CM, Reiniger LR, Stefenon VM, Curti AR, Costa LS, Paim AF.

Genet Mol Res. 2016 Aug 29;15(3). doi: 10.4238/gmr.15038410.

PMID:
27706630
25.

Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.

Virág J, Haberler C, Baksa G, Piurkó V, Hegedüs Z, Reiniger L, Bálint K, Chocholous M, Kiss A, Lotz G, Glasz T, Schaff Z, Garami M, Hegedűs B.

Pathol Oncol Res. 2017 Apr;23(2):245-252. doi: 10.1007/s12253-016-0084-3. Epub 2016 Jul 9.

26.

[The genetic landscape of chronic lymphocytic leukemia].

Marosvári D, Alpár D, Király AP, Rajnai H, Reiniger L, Bödör C.

Magy Onkol. 2016 Jun 6;60(2):118-25. Epub 2016 Feb 6. Review. Hungarian.

27.

Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.

Bödör C, Reiniger L.

Cancer Metastasis Rev. 2016 Mar;35(1):109-27. doi: 10.1007/s10555-016-9608-2. Review.

PMID:
26957091
28.

Study of the genetic diversity and structure of a natural population of Nectandra megapotamica (Spreng.) Mez. using RAPD markers.

Costa LS, Reiniger LR, Heinzmann BM, Amaral LP, Serrote CM.

Genet Mol Res. 2015 Dec 28;14(4):18407-13. doi: 10.4238/2015.December.23.28.

29.

Low CD23 expression correlates with high CD38 expression and the presence of trisomy 12 in CLL.

Kriston C, Bödör C, Szenthe K, Bánáti F, Bánkuti B, Csernus B, Reiniger L, Csomor J, Matolcsy A, Barna G.

Hematol Oncol. 2017 Mar;35(1):58-63. doi: 10.1002/hon.2244. Epub 2015 Jun 29.

PMID:
26119874
30.

Altered microRNA expression in folliculotropic and transformed mycosis fungoides.

Marosvári D, Téglási V, Csala I, Marschalkó M, Bödör C, Timár B, Csomor J, Hársing J, Reiniger L.

Pathol Oncol Res. 2015 Jul;21(3):821-5. doi: 10.1007/s12253-015-9897-8. Epub 2015 Feb 20.

PMID:
25698383
31.

Morphological and molecular characterization of Fusarium spp pathogenic to pecan tree in Brazil.

Lazarotto M, Milanesi PM, Muniz MF, Reiniger LR, Beltrame R, Harakava R, Blume E.

Genet Mol Res. 2014 Nov 11;13(4):9390-402. doi: 10.4238/2014.November.11.5.

32.

Intrauterine diagnosis and pathology of fetal choroid plexus carcinoma--a case study.

Joó GJ, Reiniger L, Papp C, Csaba A, Komáromy H, Rigó J Jr.

Pathol Res Pract. 2014 Dec;210(12):1156-9. doi: 10.1016/j.prp.2014.01.009. Epub 2014 Feb 12.

PMID:
25034609
33.

First Report of "Cylindrocarpon" pauciseptatum Associated with Black Foot Disease of Grapevine in Brazil.

Dos Santos RF, Blume E, Muniz MFB, Steckling SM, Burtet GW, Harakawa R, Garrido LR, Reiniger LRS.

Plant Dis. 2014 Apr;98(4):567. doi: 10.1094/PDIS-06-13-0635-PDN.

PMID:
30708698
34.

[The role of the pathologist in the diagnosis and therapy planning of central nervous system tumors. Prognostic and predictive markers].

Turányi E, Hanzély Z, Bálint K, Reiniger L.

Magy Onkol. 2013 Dec;57(4):215-21. doi: MagyOnkol.2013.57.4.215. Epub 2013 Nov 1. Review. Hungarian.

35.

Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.

Reiniger L, Mirabile I, Lukic A, Wadsworth JD, Linehan JM, Groves M, Lowe J, Druyeh R, Rudge P, Collinge J, Mead S, Brandner S.

Acta Neuropathol Commun. 2013 May 9;1:8. doi: 10.1186/2051-5960-1-8.

36.

First Report of Fusarium sambucinum Associated on Pinus elliottii Seeds in Brazil.

Maciel CG, Muniz MFB, Milanesi PM, Lazarotto M, Blume E, Harakawa R, Reiniger LRS, Hamann FA.

Plant Dis. 2013 Jul;97(7):995. doi: 10.1094/PDIS-11-12-1045-PDN.

PMID:
30722564
37.

[Victims of traffic occurrence submitted to surgery procedures: characteristics and perioperative complications].

Reiniger LO, de Sousa RM, Nogueira Lde S, Costa AL.

Rev Esc Enferm USP. 2012 Oct;46 Spec No:58-64. Portuguese.

38.

Lack of angiogenesis in experimental brain metastases.

Bugyik E, Dezso K, Reiniger L, László V, Tóvári J, Tímár J, Nagy P, Klepetko W, Döme B, Paku S.

J Neuropathol Exp Neurol. 2011 Nov;70(11):979-91. doi: 10.1097/NEN.0b013e318233afd7.

PMID:
22002424
39.

A novel mutation in the nerve-specific 5'UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth disease.

Murphy SM, Polke J, Manji H, Blake J, Reiniger L, Sweeney M, Houlden H, Brandner S, Reilly MM.

J Peripher Nerv Syst. 2011 Mar;16(1):65-70. doi: 10.1111/j.1529-8027.2011.00321.x.

PMID:
21504505
40.

High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia.

Balogh Z, Reiniger L, Rajnai H, Csomor J, Szepesi A, Balogh A, Deák L, Gagyi E, Bödör C, Matolcsy A.

Leuk Lymphoma. 2011 Jun;52(6):1080-4. doi: 10.3109/10428194.2011.555889. Epub 2011 Mar 21.

PMID:
21417824
41.

A painful right leg.

Smith LJ, Murphy SM, Holmes P, Reilly MM, Reiniger L, Thom M, Lunn MP.

BMJ. 2011 Mar 16;342:d1009. doi: 10.1136/bmj.d1009. No abstract available.

PMID:
21411806
42.

Brain biopsy in dementia: clinical indications and diagnostic approach.

Schott JM, Reiniger L, Thom M, Holton JL, Grieve J, Brandner S, Warren JD, Revesz T.

Acta Neuropathol. 2010 Sep;120(3):327-41. doi: 10.1007/s00401-010-0721-y. Epub 2010 Jul 18. Review.

PMID:
20640903
43.

ROR1 expression is not a unique marker of CLL.

Barna G, Mihalik R, Timár B, Tömböl J, Csende Z, Sebestyén A, Bödör C, Csernus B, Reiniger L, Peták I, Matolcsy A.

Hematol Oncol. 2011 Mar;29(1):17-21. doi: 10.1002/hon.948.

PMID:
20597086
44.

Tau, prions and Aβ: the triad of neurodegeneration.

Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S.

Acta Neuropathol. 2011 Jan;121(1):5-20. doi: 10.1007/s00401-010-0691-0. Epub 2010 May 16. Review.

45.

Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.

Gagyi E, Balogh Z, Bödör C, Timár B, Reiniger L, Deák L, Csomor J, Csernus B, Szepesi A, Matolcsy A.

Haematologica. 2008 Dec;93(12):1822-8. doi: 10.3324/haematol.13239. Epub 2008 Oct 22.

46.

MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.

Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, Matolcsy A, Bernd HW, Reiniger L, Merz H, Feller AC.

Br J Haematol. 2008 Sep;142(5):732-44. doi: 10.1111/j.1365-2141.2008.07237.x. Epub 2008 Jun 3.

PMID:
18537969
47.

Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman.

Csomor J, Bognár A, Benedek S, Sinkó J, Fekete S, Krenács L, Matolcsy A, Reiniger L.

J Clin Pathol. 2008 Jun;61(6):770-2. doi: 10.1136/jcp.2007.054585.

PMID:
18505891
48.

The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL.

Barna G, Reiniger L, Tátrai P, Kopper L, Matolcsy A.

Hematol Oncol. 2008 Sep;26(3):167-70. doi: 10.1002/hon.855.

PMID:
18381689
49.

IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).

Balogh Z, Reiniger L, Deák L, Bödör C, Csomor J, Szepesi A, Gagyi E, Kopper L, Matolcsy A.

Hematol Oncol. 2007 Jun;25(2):90-5.

PMID:
17410523
50.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].

Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.

Orv Hetil. 2006 Nov 12;147(45):2175-9. Hungarian.

PMID:
17402211

Supplemental Content

Loading ...
Support Center